1007596-95-3 Usage
Uses
Used in Medicinal Chemistry:
(3R,4R)-4-aMino-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester is used as a chiral building block for the synthesis of biologically active compounds and pharmaceuticals. Its specific stereochemistry and functional groups enable the development of novel drugs with improved efficacy and selectivity.
Used in Drug Development:
(3R,4R)-4-aMino-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester is used as a key intermediate in the synthesis of new drug candidates. Its unique structure and functional groups allow for the design and optimization of pharmaceuticals with enhanced potency, safety, and pharmacokinetic properties.
Used in Synthesis of Complex Organic Molecules:
(3R,4R)-4-aMino-3-hydroxy-piperidine-1-carboxylic acid tert-butyl ester is used as a versatile synthetic building block for the preparation of complex organic molecules. Its functional groups and stereochemistry facilitate the construction of diverse molecular architectures with potential applications in various fields, such as materials science, agrochemistry, and specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1007596-95-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,7,5,9 and 6 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1007596-95:
(9*1)+(8*0)+(7*0)+(6*7)+(5*5)+(4*9)+(3*6)+(2*9)+(1*5)=153
153 % 10 = 3
So 1007596-95-3 is a valid CAS Registry Number.
1007596-95-3Relevant articles and documents
MINERALOCORTICOID RECEPTOR ANTAGONISTS AND METHODS OF USE
-
Page/Page column 27-28, (2009/07/10)
The present invention provides a compound of Formula (I): or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I) in combination with a suitable carrier, diluent, or excipient; and methods for treating physiological disorders, particularly congestive heart failure, hypertension, diabetic nephropathy, or chronic kidney disease, comprising administering a compound of Formula (I), or a pharmaceutically acceptable salt thereof.
PYRROLE DERIVATIVES WITH ANTIBACTERIAL ACTIVITY
-
, (2008/06/13)
Compounds of formula (I) and their pharmaceutically acceptable salts are described. Processes for their preparation, pharmaceutical compositions containing them, their use as medicaments and their use in the treatment of bacterial infections are also described.
CHEMICAL COMPOUNDS
-
, (2010/02/15)
The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X1, X2, X3, X4, Ra, p, R1,Z,Y, R2, R3 and R4 are as d